Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis

NCT02016365 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Transthyretin Amyloidosis
Cardiomyopathy

Interventions

DRUG: Doxycycline
DRUG: Ursodeoxycholic acid

Sponsor

Umeå University